Bioherb
Limitations of modern medicine for treating Alcoholic Liver Disease, Liver Cirrhosis and Fatty Liver Disease
Dr. Syed Toora, B.Sc. (Hons), M.Sc. (Hons), Ph.D. in MicrobiologyDr. Rashbinder Hashimi, B.Sc. (Hons), M.Sc. (Hons), Ph.D. in Microbiology
According to published medical reports it is estimated that there are more than 2 billion people in the world with liver problems. Additionally, taking Fatty Liver Disease into account that is estimated to have already affected 7.5 million people in Canada, 5.5 million in Australia and more than 60 million in the USA, and for which there is no known treatment, the number of people living with liver disease today could be much higher than currently estimated.
Despite such a high occurrence of liver problems worldwide, media coverage of this health issue is not on par with that of heart attacks, strokes, cancer, and diabetes. Could this be due to a lack of effective treatments currently available?
A search for information from many of the top medical establishments in the world, such as the National Institute of Health, Mayo Clinic, Harvard Medical School, and Stanford Hospital and Clinics (Stanford University), reveals that modern medicine does not have much success when it comes to the treatment of liver diseases, especially end-stage liver disease and liver cancer.
Here are some documents from the world’s top medical institution regarding the treatment of non-viral liver diseases.
Treatment for Liver Cirrhosis (Fibrosis, Necrosis):
- "No FDA-approved therapy exists for either alcoholic cirrhosis or alcoholic hepatitis." The link to full document -
http://pubs.niaaa.nih.gov/publications/aa64/aa64.htm - "Liver fibrosis is usually the result of cirrhosis [...] Cirrhosis is a progressive liver disease. The damage to your liver is irreversible" The link to full document -
http://stanfordhospital.org/clinicsmedServices/COE/transplant/liver/patientEducation/chronic.html - "There are no approved antifibrotic drugs to prevent disease progression in patients with moderate ALD [Alcoholic Liver Disease]." The link to full document -
http://pubmedcentralcanada.ca/pmcc/articles/PMC3214974/ - "The goals of treatment are to slow the progression of scar tissue in the liver and to prevent or treat symptoms and complications of cirrhosis." The link to full document –
http://www.mayoclinic.org/diseases-conditions/cirrhosis/basics/treatment/con-20031617 - "The liver has great restorative power and is often able to repair some of the damage caused by alcohol. In most cases, the only damage it cannot reverse is scarring from cirrhosis." The link to full document -
http://stanfordhospital.org/clinicsmedServices/COE/transplant/liver/patientEducation/alcohol.html
Treatment for Early Stage Alcoholic Liver Disease:
- "No FDA–approved therapy exists for either alcoholic cirrhosis or alcoholic hepatitis." The link to full document -
http://pubs.niaaa.nih.gov/publications/aa64/aa64.htm - "No new drugs for ALD [Alcoholic Liver Disease] have been successfully developed since the early 1970s." The link to full document -
http://pubmedcentralcanada.ca/pmcc/articles/PMC3214974/ - "Treatment usually begins with abstinence from alcohol." The link to full document -
http://stanfordhospital.org/clinicsmedServices/COE/transplant/liver/patientEducation/alcohol.html
Treatment for Fatty Liver Disease
- "No standard treatment for nonalcoholic fatty liver disease exists." The link to full document -
http://www.mayoclinic.org/diseases-conditions/nonalcoholic-fatty-liver-disease/basics/treatment/con-20027761 - "Weight loss (ideally from changes in diet and an increase in physical activity) as the only recommended treatment for most cases of Fatty Liver Disease and NASH." The link to full document -
http://www.health.harvard.edu/newsletters/Harvard_Health_Letter/2011/January/when-the-liver-gets-fatty
The above documents undoubtedly illustrate that there are hardly any effective treatments available for any stages of liver disease. In the case of advanced liver disease (regardless of cause), medical tests and blood tests will indicate high bilirubin (jaundice), low albumin, low e-GFR (if liver-related), high INR, low platelet, liver fibrosis, necrosis or inflammation, portal vein hypertension, and in cases of viral hepatitis there will be high viral count. Based on clinical reports and medical tests, Liv-Herbal Formula has significantly improved all of the above mentioned parameters even in patients with end-stage liver disease. Any scientist, doctor, or liver patient knowledgeable about liver diseases, will not dispute that Liv-Herbal Formula is, if not the only, one of the best medicines formulated for liver diseases in modern history and at Bio-Herb Remedies Inc. we are proud of this contribution to humanity.
Page last updated: February 2018
